Literature DB >> 21969364

Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK).

Wei Zhang1, Anne-Sophie Coldefy, Stevan R Hubbard, Steven J Burden.   

Abstract

Neuromuscular synapse formation depends upon coordinated interactions between motor neurons and muscle fibers, leading to the formation of a highly specialized postsynaptic membrane and a highly differentiated nerve terminal. Synapse formation begins as motor axons approach muscles that are prepatterned in the prospective synaptic region in a manner that depends upon Lrp4, a member of the LDL receptor family, and muscle-specific kinase (MuSK), a receptor tyrosine kinase. Motor axons supply Agrin, which binds Lrp4 and stimulates further MuSK phosphorylation, stabilizing nascent synapses. How Agrin binds Lrp4 and stimulates MuSK kinase activity is poorly understood. Here, we demonstrate that Agrin binds to the N-terminal region of Lrp4, including a subset of the LDLa repeats and the first of four β-propeller domains, which promotes association between Lrp4 and MuSK and stimulates MuSK kinase activity. In addition, we show that Agrin stimulates the formation of a functional complex between Lrp4 and MuSK on the surface of myotubes in the absence of the transmembrane and intracellular domains of Lrp4. Further, we demonstrate that the first Ig-like domain in MuSK, which shares homology with the NGF-binding region in Tropomyosin Receptor Kinase (TrKA), is required for MuSK to bind Lrp4. These findings suggest that Lrp4 is a cis-acting ligand for MuSK, whereas Agrin functions as an allosteric and paracrine regulator to promote association between Lrp4 and MuSK.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969364      PMCID: PMC3220470          DOI: 10.1074/jbc.M111.279307

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome.

Authors:  Yun Li; Barbara Pawlik; Nursel Elcioglu; Mona Aglan; Hülya Kayserili; Gökhan Yigit; Ferda Percin; Frances Goodman; Gudrun Nürnberg; Asim Cenani; Jill Urquhart; Boi-Dinh Chung; Samira Ismail; Khalda Amr; Ayca D Aslanger; Christian Becker; Christian Netzer; Pete Scambler; Wafaa Eyaid; Hanan Hamamy; Jill Clayton-Smith; Raoul Hennekam; Peter Nürnberg; Joachim Herz; Samia A Temtamy; Bernd Wollnik
Journal:  Am J Hum Genet       Date:  2010-04-08       Impact factor: 11.025

Review 2.  Wnt signaling and stem cell control.

Authors:  Roel Nusse
Journal:  Cell Res       Date:  2008-05       Impact factor: 25.617

3.  Crystal structure of the frizzled-like cysteine-rich domain of the receptor tyrosine kinase MuSK.

Authors:  Amy L Stiegler; Steven J Burden; Stevan R Hubbard
Journal:  J Mol Biol       Date:  2009-08-04       Impact factor: 5.469

Review 4.  Beyond the cell surface: new mechanisms of receptor function.

Authors:  Carlos F Ibáñez
Journal:  Biochem Biophys Res Commun       Date:  2010-05-21       Impact factor: 3.575

5.  LRP4 serves as a coreceptor of agrin.

Authors:  Bin Zhang; Shiwen Luo; Qiang Wang; Tatsuo Suzuki; Wen C Xiong; Lin Mei
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

Review 6.  The LDL receptor.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

7.  Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6.

Authors:  Eric Bourhis; Christine Tam; Yvonne Franke; J Fernando Bazan; James Ernst; Jiyoung Hwang; Mike Costa; Andrea G Cochran; Rami N Hannoush
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

8.  Ligand-induced structural transitions in ErbB receptor extracellular domains.

Authors:  Jessica P Dawson; Zimei Bu; Mark A Lemmon
Journal:  Structure       Date:  2007-08       Impact factor: 5.006

9.  Lrp4 modulates extracellular integration of cell signaling pathways in development.

Authors:  Atsushi Ohazama; Eric B Johnson; Masato S Ota; Hong Y Choi; Hong J Choi; Thantrira Porntaveetus; Shelly Oommen; Nobuyuki Itoh; Kazuhiro Eto; Amel Gritli-Linde; Joachim Herz; Paul T Sharpe
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

10.  Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.

Authors:  Hong Y Choi; Marco Dieckmann; Joachim Herz; Andreas Niemeier
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more
  58 in total

Review 1.  Wnt signaling in neuromuscular junction development.

Authors:  Kate Koles; Vivian Budnik
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06       Impact factor: 10.005

2.  Tracking the origin and divergence of cholinesterases and neuroligins: the evolution of synaptic proteins.

Authors:  Nicolas Lenfant; Thierry Hotelier; Yves Bourne; Pascale Marchot; Arnaud Chatonnet
Journal:  J Mol Neurosci       Date:  2014-01-05       Impact factor: 3.444

3.  Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.

Authors:  Chengyong Shen; Yisheng Lu; Bin Zhang; Dwight Figueiredo; Jonathan Bean; Jiung Jung; Haitao Wu; Arnab Barik; Dong-Min Yin; Wen-Cheng Xiong; Lin Mei
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

4.  Building a synapse: a complex matter.

Authors:  Young-Jun Kim; Mihaela Serpe
Journal:  Fly (Austin)       Date:  2013-04-08       Impact factor: 2.160

5.  The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

Authors:  Michael D Paul; Kalina Hristova
Journal:  Chem Rev       Date:  2018-12-27       Impact factor: 60.622

6.  Animal models of antimuscle-specific kinase myasthenia.

Authors:  David P Richman; Kayoko Nishi; Michael J Ferns; Joachim Schnier; Peter Pytel; Ricardo A Maselli; Mark A Agius
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

Review 7.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

8.  MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.

Authors:  Maartje G Huijbers; Wei Zhang; Rinse Klooster; Erik H Niks; Matthew B Friese; Kirsten R Straasheijm; Peter E Thijssen; Hans Vrolijk; Jaap J Plomp; Pauline Vogels; Mario Losen; Silvère M Van der Maarel; Steven J Burden; Jan J Verschuuren
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

9.  LRP4 is critical for neuromuscular junction maintenance.

Authors:  Arnab Barik; Yisheng Lu; Anupama Sathyamurthy; Andrew Bowman; Chengyong Shen; Lei Li; Wen-cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

10.  LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.

Authors:  Bisei Ohkawara; Macarena Cabrera-Serrano; Tomohiko Nakata; Margherita Milone; Nobuyuki Asai; Kenyu Ito; Mikako Ito; Akio Masuda; Yasutomo Ito; Andrew G Engel; Kinji Ohno
Journal:  Hum Mol Genet       Date:  2013-11-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.